Authors:
SHAPIRO AD
GILCHRIST GS
HOOTS WK
COOPER HA
GASTINEAU DA
Citation: Ad. Shapiro et al., PROSPECTIVE, RANDOMIZED TRIAL OF 2 DOSES OF RFVIIA (NOVOSEVEN) IN HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING SURGERY, Thrombosis and haemostasis, 80(5), 1998, pp. 773-778
Authors:
SHAPIRO AD
WHITE GC
KIM HC
LUSHER JM
BERGMAN GE
Citation: Ad. Shapiro et al., EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN HEMOPHILIA-B PATIENTS UNDERGOING SURGICAL-PROCEDURES, Haemophilia, 3(4), 1997, pp. 247-253
Citation: Wp. Fay et al., HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) DEFICIENCY - CHARACTERIZATION OF A LARGE KINDRED WITH A NULL MUTATION IN THE PAI-1 GENE, Blood, 90(1), 1997, pp. 204-208
Authors:
SHAPIRO AD
CENTURY K
DAHLBECK D
STASKAWICZ B
Citation: Ad. Shapiro et al., GENETIC DISSECTION OF SIGNAL-TRANSDUCTION IN ARABIDOPSIS DISEASE RESISTANCE, Molecular biology of the cell, 7, 1996, pp. 63-63
Authors:
SHAPIRO AD
RAGNI MV
LUSHER JM
CULBERT S
KOERPER MA
BERGMAN GE
HANNAN MM
Citation: Ad. Shapiro et al., SAFETY AND EFFICACY OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 75(1), 1996, pp. 30-35
Citation: Ad. Shapiro, AMERICAN EXPERIENCE WITH HOME-USE OF NOVOSEVEN(R) - RECOMBINANT FACTOR VIIA IN HEMOPHILIACS WITH INHIBITORS, Haemostasis, 26, 1996, pp. 143-149
Citation: Ad. Shapiro, EXPLAINING PSYCHOLOGICAL DISTRESS IN A SAMPLE OF REMARRIED AND DIVORCED PERSONS - THE INFLUENCE OF ECONOMIC DISTRESS, Journal of family issues, 17(2), 1996, pp. 186-203
Citation: Wp. Fay et Ad. Shapiro, ANALYSIS OF A LARGE PEDIGREE WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY, Circulation, 94(8), 1996, pp. 2689-2689
Authors:
MENACHE D
ARONSON DL
DARR F
MONTGOMERY RR
GILL JC
KRESSLER CM
LUSHER JM
PHATAK PD
SHAPIRO AD
THOMPSON AR
WHITE GC
Citation: D. Menache et al., PHARMACOKINETICS OF VON-WILLEBRAND-FACTOR AND FACTOR-VIIIC IN PATIENTS WITH SEVERE VON-WILLEBRAND DISEASE (TYPE-3 VWD) - ESTIMATION OF THE RATE OF FACTOR-VIIIC SYNTHESIS, British Journal of Haematology, 94(4), 1996, pp. 740-745
Citation: Ad. Shapiro et al., A REPORT OF SEVERE INTRACRANIAL BLEEDING IN AN INFANT WITH PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY - SUCCESSFUL TREATMENT WITH ANTI-FIBRINOLYTIC THERAPY AND SURGICAL EVACUATION, Blood, 88(10), 1996, pp. 134-134
Authors:
KURCZYNSKI E
LUSHER JM
PITEL P
SHAPIRO AD
BERGMAN GE
Citation: E. Kurczynski et al., SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLYTREATED CHILDREN WITH HEMOPHILIA-B, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 211-216
Authors:
WARRIER I
KASPER CK
WHITE GC
SHAPIRO AD
BERGMAN GE
Citation: I. Warrier et al., SAFETY OF HIGH-DOSES OF A MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE, American journal of hematology, 49(1), 1995, pp. 92-94
Authors:
WHITE GC
SHAPIRO AD
RAGNI MV
COURTER SG
TUBRIDY KL
KAYE JA
KESSLER CM
Citation: Gc. White et al., A PHARMACOKINETIC EVALUATION OF RECOMBINANT HUMAN FACTOR-IX (RHFIX) IN PATIENTS WITH SEVERE HEMOPHILIA-B, Thrombosis and haemostasis, 73(6), 1995, pp. 1015-1015
Authors:
WHITE GC
SHAPIRO AD
KURCZYNSKI EM
KIM HC
BERGMAN GE
BENJAMIN L
BROOKS P
CORNELL NJ
CZAPEK E
DAVIS RT
DIMICHELE D
DJULBEGOVIC B
GILL JC
GOLDSMITH J
GORDON ME
GREEN D
GREENBERG S
GRIBBLE J
HILGARTNER M
HODDER F
HUTTER JJ
JANCO R
KASPER C
KESSLER C
LUSHER J
MARTINOWITZ U
OPENSHAW TH
PHILLIPS M
PITEL P
POTOLSKY A
PRESTON FE
RAUSEN A
SAVIDGE G
SEXAUER C
SHURAFA M
SMITH G
SWEENEY J
TELFORD M
WILDE J
WILSON W
Citation: Gc. White et al., VARIABILITY OF IN-VIVO RECOVERY OF FACTOR-IX AFTER INFUSION OF MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX CONCENTRATES IN PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 73(5), 1995, pp. 779-784
Authors:
KRONER BL
GOEDERT JJ
BLATTNER WA
WILSON SE
CARRINGTON MN
MANN DL
OBRIEN SJ
WILLOUGHBY A
KESSEL W
DONFIELD SM
MCKINLAY SM
ALEDORT LM
ARKIN S
EYSTER ME
PATTISHALL EG
HILGARTNER MW
KONKLE B
WHITE GC
COHEN AR
BRAY GL
LUBAN N
KESSLER CM
RAGNI MV
LEDERMAN MM
LEISSINGER C
SIROIS P
MANCOJOHNSON M
DEMOERLOOSE P
MAHE A
HATZAKIS A
MANDALAKI T
SCHRAMM W
EICHINGER S
STINGL G
GOMPERTS ED
HOOTS WK
LOVELAND KA
KISKER CT
STEHBENS AA
CONTANT CF
HUSZTI H
SWINDELLS S
MANGOS J
WARRIER I
SHAPIRO AD
DAVIGNON GF
WICKLUND BM
WINKLER C
Citation: Bl. Kroner et al., CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS, AIDS, 9(3), 1995, pp. 275-280
Citation: Ad. Shapiro et Sr. Pfeffer, QUANTITATIVE-ANALYSIS OF THE INTERACTIONS BETWEEN PRENYL RAB9, GDP DISSOCIATION INHIBITOR-ALPHA, AND GUANINE-NUCLEOTIDES, The Journal of biological chemistry, 270(19), 1995, pp. 11085-11090
Authors:
GERTNER JM
KAUFMAN FR
DONFIELD SM
SLEEPER LA
SHAPIRO AD
HOWARD C
GOMPERTS ED
HILGARTNER MW
Citation: Jm. Gertner et al., DELAYED SOMATIC GROWTH AND PUBERTAL DEVELOPMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIAC BOYS - HEMOPHILIA GROWTH AND DEVELOPMENT STUDY, The Journal of pediatrics, 124(6), 1994, pp. 896-902
Authors:
RIEDERER MA
SOLDATI T
SHAPIRO AD
LIN J
PFEFFER SR
Citation: Ma. Riederer et al., LYSOSOME BIOGENESIS REQUIRES RAB9 FUNCTION AND RECEPTOR RECYCLING FROM ENDOSOMES TO THE TRANS-GOLGI NETWORK, The Journal of cell biology, 125(3), 1994, pp. 573-582
Authors:
DIRACSVEJSTRUP AB
SOLDATI T
SHAPIRO AD
PFEFFER SR
Citation: Ab. Diracsvejstrup et al., RAB-GDI PRESENTS FUNCTIONAL RAB9 TO THE INTRACELLULAR-TRANSPORT MACHINERY AND CONTRIBUTES SELECTIVITY TO RAB9 MEMBRANE RECRUITMENT, The Journal of biological chemistry, 269(22), 1994, pp. 15427-15430
Authors:
FAY WP
EITZMAN DT
SHAPIRO AD
MADISON EL
GINSBURG D
Citation: Wp. Fay et al., PLATELETS INHIBIT FIBRINOLYSIS IN-VITRO BY BOTH PLASMINOGEN-ACTIVATORINHIBITOR-1 DEPENDENT AND INHIBITOR-1 INDEPENDENT MECHANISMS, Blood, 83(2), 1994, pp. 351-356
Authors:
SHAPIRO AD
CLARKE SL
CHRISTIAN JM
ODOM LF
HATHAWAY WE
Citation: Ad. Shapiro et al., THROMBOSIS IN CHILDREN RECEIVING L-ASPARAGINASE - DETERMINING PATIENTS AT RISK, The American journal of pediatric hematology/oncology, 15(4), 1993, pp. 400-405